LSD1-IN-51
LSD1-IN-51 is a selective lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 value of 8.7 nM. LSD1-IN-51 selectively inhibits H3K4me1/2 demethylation by binding to the FAD domain of LSD1, while disrupting the interaction between LSD1 and multiprotein complexes such as HDAC1/2 and CoREST. LSD1-IN-51 can be used for cancer research.
For research use only. We do not sell to patients.
- CAS No.: 1423715-30-3
- Formula: C16H16ClN3O4S
- Molecular Weight:381.83
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
LSD1 8.7 nM (IC50) |
In Vitro
LSD1-IN-51 (Compound 29) potently inhibits LSD1 enzymatic activity in a cell-free biochemical assay system in vitro at 60 min, with an IC50 value of 8.7 nM[1].
LSD1-IN-51 (96 h) exhibits no significant cell growth inhibitory effect or heme oxygenase-1 (HMOX1) gene transcriptional induction activity in T-47D breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 1423715-30-3
-
Molecular Weight 381.83
-
Formula C16H16ClN3O4S
-
SMILES
C(N/N=C(\C)/C1=C(O)C=CC(Cl)=C1)(=O)C2=CC(S(NC)(=O)=O)=CC=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)